Chile’s CFR Shareholders OK Buyout For South Africa’s Adcock Ingram
This article was originally published in PharmAsia News
Executive Summary
Chile's CFR Pharmaceuticals shareholders voted in favor of a $12.8 billion takeover of South Africa's Adcock Ingram, despite strong opposition from a pair of major stakeholders.